A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology
- 12 September 2009
- journal article
- review article
- Published by Springer Nature in Immunologic Research
- Vol. 46 (1), 59-71
- https://doi.org/10.1007/s12026-009-8125-6
Abstract
Understanding mechanisms of tumor escape are critically important not only to improving our knowledge of cancer biology, but also for the overall development of more effective anti-neoplastic therapies. Our laboratory focuses on mechanisms of apoptotic resistance, with emphasis on Fas loss of function as an important determinant of tumor progression. Our work in solid tumor systems has led to the identification of interferon regulatory factor-8 (IRF-8) as a differentially expressed gene important for tumor cell response to cytotoxicity, including Fas-mediated apoptosis and host–anti-tumor immunosurveillance mechanisms. Although IRF-8 was originally identified in the regulation of normal and neoplastic myeloid cell development, these findings revealed a new functional role for IRF-8 in non-hematopoietic malignancies and establish a molecular basis for its potential manipulation during cancer therapy.Keywords
This publication has 42 references indexed in Scilit:
- Myeloid-Derived Suppressor Cells: Linking Inflammation and CancerThe Journal of Immunology, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor–Initiated Apoptosis via Repression of FLICE-like Protein ExpressionCancer Research, 2009
- Immune Consequences of Protracted Host-Tumor Interactions in a Transgenic Mouse Model of Mammary CarcinomaCancer Investigation, 2008
- Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNature Reviews Immunology, 2007
- Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-κB, and PU.1Published by Elsevier ,2006
- Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2Blood, 2004
- Validation of a model of colon cancer progressionThe Journal of Pathology, 2000
- The Hallmarks of CancerCell, 2000
- Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding ProteinThe Journal of Experimental Medicine, 1999